These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
766 related articles for article (PubMed ID: 12750262)
1. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262 [TBL] [Abstract][Full Text] [Related]
2. Low-dose dietary phytoestrogen abrogates tamoxifen-associated mammary tumor prevention. Liu B; Edgerton S; Yang X; Kim A; Ordonez-Ercan D; Mason T; Alvarez K; McKimmey C; Liu N; Thor A Cancer Res; 2005 Feb; 65(3):879-86. PubMed ID: 15705886 [TBL] [Abstract][Full Text] [Related]
3. Mammary tumor heterogeneity in wt-ErbB-2 transgenic mice. Kosanke S; Edgerton SM; Moore D; Yang X; Mason T; Alvarez K; Jones L; Kim A; Thor AD Comp Med; 2004 Jun; 54(3):280-7. PubMed ID: 15253274 [TBL] [Abstract][Full Text] [Related]
4. Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats. Manjanatha MG; Shelton S; Bishop ME; Lyn-Cook LE; Aidoo A Carcinogenesis; 2006 Dec; 27(12):2555-64. PubMed ID: 17127718 [TBL] [Abstract][Full Text] [Related]
5. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729 [TBL] [Abstract][Full Text] [Related]
6. Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model. Ménard S; Aiello P; Tagliabue E; Rumio C; Lollini PL; Colnaghi MI; Balsari A Cancer Res; 2000 Jan; 60(2):273-5. PubMed ID: 10667575 [TBL] [Abstract][Full Text] [Related]
7. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice. Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379 [TBL] [Abstract][Full Text] [Related]
8. Modulation of mammary tumor development in Tg.NK (MMTV/c-neu) mice by dietary fatty acids and life stage-specific exposure to phytoestrogens. Luijten M; Verhoef A; Dormans JA; Beems RB; Cremers HW; Nagelkerke NJ; Adlercreutz H; Peñalvo JL; Piersma AH Reprod Toxicol; 2007; 23(3):407-13. PubMed ID: 17229545 [TBL] [Abstract][Full Text] [Related]
9. Dietary effects of soy isoflavones daidzein and genistein on 7,12-dimethylbenz[a]anthracene-induced mammary mutagenesis and carcinogenesis in ovariectomized Big Blue transgenic rats. Manjanatha M; Shelton S; Bishop M; Lyn-Cook L; Aidoo A Carcinogenesis; 2006 Oct; 27(10):1970-9. PubMed ID: 16709578 [TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis. Lubet RA; Boring D; Steele VE; Ruppert JM; Juliana MM; Grubbs CJ Cancer Prev Res (Phila); 2009 Feb; 2(2):161-7. PubMed ID: 19196723 [TBL] [Abstract][Full Text] [Related]
11. A transgenic mouse model for mammary carcinogenesis. Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874 [TBL] [Abstract][Full Text] [Related]
12. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645 [TBL] [Abstract][Full Text] [Related]
13. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types. Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070 [TBL] [Abstract][Full Text] [Related]
14. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency. Swanson SM; Christov K Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682 [TBL] [Abstract][Full Text] [Related]
15. The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice. Wu K; Zhang Y; Xu XC; Hill J; Celestino J; Kim HT; Mohsin SK; Hilsenbeck SG; Lamph WW; Bissonette R; Brown PH Cancer Res; 2002 Nov; 62(22):6376-80. PubMed ID: 12438218 [TBL] [Abstract][Full Text] [Related]
16. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats. Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162 [TBL] [Abstract][Full Text] [Related]
17. Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate. Chiesa G; Rigamonti E; Lovati MR; Disconzi E; Soldati S; Sacco MG; Catò EM; Patton V; Scanziani E; Vezzoni P; Arnoldi A; Locati D; Sirtori CR Mol Nutr Food Res; 2008 Oct; 52(10):1121-9. PubMed ID: 18655005 [TBL] [Abstract][Full Text] [Related]
18. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Chen J; Hui E; Ip T; Thompson LU Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004 [TBL] [Abstract][Full Text] [Related]
19. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice. Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408 [TBL] [Abstract][Full Text] [Related]